Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

749 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, Scholten D, Berres ML, Zimmermann H, Streetz KL, Tacke F, Hillebrandt S, Schmitz P, Keppeler H, Berg T, Dahl E, Gassler N, Friedman SL, Trautwein C. Wasmuth HE, et al. Among authors: dahl e. Gastroenterology. 2009 Jul;137(1):309-19, 319.e1-3. doi: 10.1053/j.gastro.2009.03.053. Epub 2009 Apr 1. Gastroenterology. 2009. PMID: 19344719 Free PMC article.
ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Rose M, Kloten V, Noetzel E, Gola L, Ehling J, Heide T, Meurer SK, Gaiko-Shcherbak A, Sechi AS, Huth S, Weiskirchen R, Klaas O, Antonopoulos W, Lin Q, Wagner W, Veeck J, Gremse F, Steitz J, Knüchel R, Dahl E. Rose M, et al. Among authors: dahl e. Mol Cancer. 2017 Feb 23;16(1):44. doi: 10.1186/s12943-017-0610-2. Mol Cancer. 2017. PMID: 28231808 Free PMC article.
High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable Prognosis.
Dreyer VJ, Shi JX, Rose M, Onyuro MT, Steib F, Hilgers L, Seillier L, Dietrich J, Riese J, Meurer SK, Weiskirchen R, Neumann U, Heij L, Luedde T, Loosen SH, Lurje I, Lurje G, Gaisa NT, Jonigk D, Bednarsch J, Dahl E, Brüchle NO. Dreyer VJ, et al. Among authors: dahl e. Cancers (Basel). 2024 Oct 29;16(21):3647. doi: 10.3390/cancers16213647. Cancers (Basel). 2024. PMID: 39518085 Free PMC article.
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Möhlendick B, Schönfelder K, Breuckmann K, Elsner C, Babel N, Balfanz P, Dahl E, Dreher M, Fistera D, Herbstreit F, Hölzer B, Koch M, Kohnle M, Marx N, Risse J, Schmidt K, Skrzypczyk S, Sutharsan S, Taube C, Westhoff TH, Jöckel KH, Dittmer U, Siffert W, Kribben A. Möhlendick B, et al. Among authors: dahl e. Pharmacogenet Genomics. 2021 Oct 1;31(8):165-171. doi: 10.1097/FPC.0000000000000436. Pharmacogenet Genomics. 2021. PMID: 34001841 Free PMC article.
749 results